Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.13 (
acetyl-CoA synthetase
)
451
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Metastasis is the main cause of cancer-associated deaths, yet this complex process is still not well understood. Many studies have shown that acetate is involved in cancer metastasis, but the molecular mechanisms remain to be elucidated. In the present study, we first measured the effect of acetate on zinc finger transcriptional repressor
SNAI1
and
acetyl-CoA synthetase
2 (ACSS2) under glucose limitation in renal cell carcinoma cell lines, 786-O and ACHN. Then, RNA interference and overexpression of ACSS2 were used to detect the role of acetate on
SNAI1
expression and cell migration. Finally, chromatin immunoprecipitation assay (ChIP) was used to investigate the regulatory mechanism of acetate on
SNAI1
expression. The results showed that acetate increased the expressions of
SNAI1
and ACSS2 under glucose limitation. ACSS2 knockdown significantly decreased acetate-induced
SNAI1
expression and cell migration, whereas overexpression of ACSS2 increased
SNAI1
level and histone H3K27 acetylation (H3K27ac). ChIP results revealed that acetate increased H3K27ac levels in regulatory region of
SNAI1
, but did not increase ACSS2-binding ability. Our study identified a novel inducer, acetate, which can promote
SNAI1
expression by ACSS2-mediated histone acetylation in partly. This finding has important implication in treatment of metastatic cancers.
...
PMID:Acetate promotes SNAI1 expression by ACSS2-mediated histone acetylation under glucose limitation in renal cell carcinoma cell. 3245 71